| Registration number: |
E016390 |
| European Patent number: |
EP2662091 |
| Application number: |
EP13164403.1 |
| Filing date of the application: |
30.11.2007 |
| Date of the grant of the European patent: |
22.08.2018 |
| Date of the publication of the translation: |
15.01.2019 |
| Status: |
European patent validated in Estonia |
| Fees paid for the years of validity: |
18 |
| IPC class: |
A61K 39/395
C07K 16/28
|
| Examiner: |
Reet Kask
|
| Owner: |
Novartis AG |
| Owner: |
Oklahoma Medical Research Foundation |
| Patent attorney: |
Anneli Kapp |
| Estonian title |
Anti-P-selektiini antikehad ja nende kasutamise meetodid põletikuliste haiguste ravis |
| Translation of the patent specification:
|
Display translation of the patent specification
|
| |
|
| Display: |
EXAMINATION |
DATA OF THE FEES |
